Furthermore, diagnostic models based on 18F-FDG PET metabolic parameters (SUVR) and clinical variables, including patient signs (fever), medical history (cholecystolithiasis) and laboratory examination (CEA > 5 ng/ml), can effectively help differentiate nonmetastatic GBC and cholecystitis. Here, CEACAM5 is linked to cholecystolithiasis.